CONMED Raises FY23 Adj EPS Outlook From $3.30-$3.50 To $3.40-$3.55, Consensus $3.42
Portfolio Pulse from Benzinga Newsdesk
CONMED has increased its FY23 adjusted EPS outlook from $3.30-$3.50 to $3.40-$3.55, which is above the consensus estimate of $3.42.
July 26, 2023 | 9:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CONMED's raised FY23 adjusted EPS outlook could potentially lead to a positive impact on its stock price.
CONMED's raised FY23 adjusted EPS outlook is above the consensus estimate, which could be seen as a positive signal by investors and potentially lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100